About 600 results
Open links in new tab
  1. Pioneering AI Drug Discovery | Recursion

    All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.

  2. Press Releases & Recursion News | Recursion

    Sep 1, 2017 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!

  3. Our AI Drug Discovery & Development Story | Recursion

    Nov 5, 2013 · We are not here to make a few medicines. We are here to reimagine how medicines are made. The Recursion mindset is the deep belief and commitment to …

  4. Recursion's Drug Discovery Pipeline | Recursion

    Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high …

  5. Recursion Announces Completion of NVIDIA-Powered BioHive-2, …

    May 13, 2024 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, …

  6. Careers at Recursion: Join Our Mission | Recursion

    Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!

  7. Ben Taylor - recursion.com

    Ben Taylor comes to Recursion after over 4 years as the CFO of Exscientia. Ben has more than two decades of experience in healthcare investment banking and executive roles, including 15 …

  8. Our Unique Approach to AI Drug Discovery | Recursion

    Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects …

  9. How a First-of-its-Kind “Microglia Map” from Recursion and Roche …

    Oct 29, 2025 · A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a …

  10. Recursion announced progress on REC-7735, with nomination as a Development Candidate and IND-enabling studies now underway. REC-7735 is a precision-designed PI3K⍺ H1047R …